Appian Way Asset Management LP Has $1.58 Million Position in DarioHealth Corp. (NASDAQ:DRIO)

Appian Way Asset Management LP grew its position in DarioHealth Corp. (NASDAQ:DRIO) by 2.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,410,870 shares of the company’s stock after buying an additional 34,990 shares during the quarter. DarioHealth accounts for about 0.4% of Appian Way Asset Management LP’s portfolio, making the stock its 28th largest holding. Appian Way Asset Management LP owned about 4.14% of DarioHealth worth $1,580,000 at the end of the most recent reporting period.

Separately, DLK Investment Management LLC raised its position in shares of DarioHealth by 71.6% in the 3rd quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock valued at $113,000 after buying an additional 41,943 shares in the last quarter. Hedge funds and other institutional investors own 33.39% of the company’s stock.

DarioHealth Price Performance

Shares of NASDAQ:DRIO opened at $0.79 on Friday. The firm has a 50 day moving average of $0.93 and a 200-day moving average of $1.08. The stock has a market capitalization of $26.90 million, a PE ratio of -0.84 and a beta of 1.51. The company has a current ratio of 1.57, a quick ratio of 1.32 and a debt-to-equity ratio of 0.35. DarioHealth Corp. has a 12 month low of $0.67 and a 12 month high of $2.60.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.